About Renue Life Sciences
Renue Life Sciences is a private company based in San Carlos, California, incorporated in 2026 in Delaware. It has reported $250,000 raised in one offering on Form D since October 2026. Its chief executive is Samuel Perli.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Oct 14, 2026 | $250,000of $3.0M target | 8 | $31,250 | Securities on exercise, Issuance of Simple Agreements for Future EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Renue Life Sciences's Form D filed Oct 14, 2026.
